• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    20 Stocks Moving in Monday's Pre-Market Session

    12/6/21 6:50:59 AM ET
    $AEI
    $AHI
    $ARDX
    $ASTS
    Real Estate
    Finance
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $AEI alert in real time by email

    Gainers

    • CF Acquisition Corp. VI (NASDAQ:CFVI) rose 23.6% to $14.75 in pre-market trading on continued strength following the SPACs announcement of a merger with Rumble.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) rose 15.6% to $51.99 in pre-market trading. Trump Media & Technology Group Corp. and Digital World Acquisition confirmed on Saturday $1 billion "PIPE" investment in committed capital to fund business.
    • GCP Applied Technologies Inc. (NYSE:GCP) rose 12.5% to $30.39 in pre-market trading. Saint-Gobain announced plans to buy GCP Applied Technologies in a deal valued at around $2.3 billion.
    • Phunware, Inc. (NASDAQ:PHUN) rose 11.9% to $3.39 in pre-market trading after dipping over 13% on Friday.
    • Remark Holdings, Inc. (NASDAQ:MARK) rose 11.2% to $1.19 in pre-market trading after dropping 10% on Friday.
    • Sorrento Therapeutics, Inc. (NASDAQ:SRNE) rose 7.2% to $5.30 in pre-market trading. Sorrento, earlier Sunday, announced publication of a series of novel SARS-CoV-2 main protease (MPRO) inhibitors for potential treatment of COVID-19 patients infected with SARS-CoV-2 variants of concern, including omicron.
    • LG Display Co., Ltd. (NYSE:LPL) rose 6.9% to $9.12 in pre-market trading.
    • Ardelyx, Inc. (NASDAQ:ARDX) rose 5.3% to $1.60 in pre-market trading. Ladenburg Thalmann, last week, upgraded the stock from Neutral to Buy and announced a $6 price target. Also, Citigroup maintained a Buy rating and raised its price target from $7 to $13..
    • Chindata Group Holdings Limited (NASDAQ:CD) rose 5.1% to $6.22 in pre-market trading. Chindata Group recently named Jing Ju as CEO.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Check out these big penny stock gainers and losers

    Losers

    • Alset EHome International Inc. (NASDAQ:AEI) fell 37.1% to $0.68 in pre-market trading after the company priced its $30 million underwritten public offering.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) shares fell 12.9% to $8.05 in pre-market trading. AST SpaceMobile, last month, posted Q3 EPS of $0.07 on sales of $2.45 million.
    • Bitfarms Ltd. (NASDAQ:BITF) fell 10.7% to $5.58 in pre-market trading after tumbling 13% on Friday.
    • Hut 8 Mining Corp. (NASDAQ:HUT) shares fell 10.4% to $8.40 in pre-market trading. Hut 8 Mining, last week, reported it mined 265 Bitcoin in November, down from prior months.
    • Riot Blockchain, Inc. (NASDAQ:RIOT) shares fell 9.5% to $25.90 in pre-market trading after declining around 13% on Friday.
    • Ebang International Holdings Inc. (NASDAQ:EBON) fell 9.2% to $1.18 in pre-market trading. Ebang International will hold its 2021 Annual General Meeting of on December 15, 2021.
    • Conifer Holdings, Inc. (NASDAQ:CNFR) fell 8.6% to $2.01 in pre-market trading. Conifer Holdings, last month, posted a Q3 loss of $0.18 per share.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) fell 8.1% to $38.25 in pre-market trading amid a drop in the price of Bitcoin and Ethereum.
    • Power & Digital Infrastructure Acquisition Corp. (NASDAQ:XPDI) shares fell 6.9% to $11.11 in pre-market trading after dropping more than 10% on Friday.
    • Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) fell 6.1% to $4.31 in pre-market trading. Cumberland Pharmaceuticals, last week, announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 5.2% to $4.36 in pre-market trading. Advanced Human Imaging, last month, announced closing of $10.5 million U.S. initial public offering.
    Get the next $AEI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEI
    $AHI
    $ARDX
    $ASTS

    CompanyDatePrice TargetRatingAnalyst
    Hut 8 Corp.
    $HUT
    3/23/2026$136.00Buy
    Arete
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    AST SpaceMobile Inc.
    $ASTS
    1/13/2026$105.00Buy → Neutral
    B. Riley Securities
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    AST SpaceMobile Inc.
    $ASTS
    1/7/2026$45.60Sector Perform → Sector Underperform
    Scotiabank
    More analyst ratings

    $AEI
    $AHI
    $ARDX
    $ASTS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by AST SpaceMobile Inc.

    SCHEDULE 13D/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    4/24/26 8:10:24 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Cumberland Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)

    4/24/26 5:08:24 PM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Ebang International Holdings Inc.

    6-K - Ebang International Holdings Inc. (0001799290) (Filer)

    4/24/26 4:20:04 PM ET
    $EBON
    Semiconductors
    Technology

    $AEI
    $AHI
    $ARDX
    $ASTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Ettenberg Felecia

    3 - ARDELYX, INC. (0001437402) (Issuer)

    4/22/26 4:04:27 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Nowaid Zabi

    4 - MARA Holdings, Inc. (0001507605) (Issuer)

    4/21/26 7:00:12 PM ET
    $MARA
    EDP Services
    Technology

    SEC Form 4 filed by Khan Salman Hassan

    4 - MARA Holdings, Inc. (0001507605) (Issuer)

    4/21/26 7:00:10 PM ET
    $MARA
    EDP Services
    Technology

    $AEI
    $AHI
    $ARDX
    $ASTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Arete initiated coverage on Hut 8 Mining with a new price target

    Arete initiated coverage of Hut 8 Mining with a rating of Buy and set a new price target of $136.00

    3/23/26 8:29:00 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    Morgan Stanley initiated coverage on MARA Holdings Inc. with a new price target

    Morgan Stanley initiated coverage of MARA Holdings Inc. with a rating of Underweight and set a new price target of $8.00

    2/9/26 7:01:42 AM ET
    $MARA
    EDP Services
    Technology

    $AEI
    $AHI
    $ARDX
    $ASTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Larson Keith R bought $50,000 worth of shares (625 units at $80.00) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/29/25 6:00:02 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Director Larson Keith R bought $50,064 worth of shares (715 units at $70.02) (SEC Form 4)

    4 - AST SpaceMobile, Inc. (0001780312) (Issuer)

    12/17/25 6:00:10 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $AEI
    $AHI
    $ARDX
    $ASTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ebang International Reports Financial Results for Fiscal Year 2025

    IRVING, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (NASDAQ:EBON, the "Company, " "we" or "our")), today announced its financial results for the fiscal year ended December 31, 2025. Operational and Financial Highlights for Fiscal Year 2025 Total net revenues in the 2025 fiscal year increased by 11.4% to US$6.5 million, from US$5.9 million in the 2024 fiscal year. Gross profit in the 2025 fiscal year was US$0.4 million, compared to a gross profit of US$1.2 million in the 2024 fiscal year. Net loss in the 2025 fiscal year was US$14.2 million, compared to US$20.9 million in the 2024 fiscal year. Mr. Dong Hu, Chairman and Chief Executive Officer of the Comp

    4/24/26 4:15:00 PM ET
    $EBON
    Semiconductors
    Technology

    Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex

    Transaction unlocks $100 million in value for Cumberland Sharpens focus on Orphan Drug Candidates to address Unmet Medical NeedsNASHVILLE, Tenn., April 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a U.S. specialty pharmaceutical company, today announced it has entered into an agreement with an affiliate of Apotex ("Apotex"), the largest Canadian based pharmaceutical company to integrate their branded U.S. businesses. Under the terms of the agreement, Apotex will acquire Cumberland's line of branded pharmaceuticals for cash consideration of $100 million, and create a platform to deliver specialty medicines that improve the quality of patient care. The transaction is

    4/23/26 9:00:00 AM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

    WALTHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced an abstract, exploring the patient characteristics associated with irritable bowel syndrome with constipation (IBS-C) treatment patterns and their impact on gastrointestinal (GI) related healthcare resource utilization (HCRU), has been accepted as a poster presentation at the upcoming Digestive Disease Week Conference (DDW), to be held May 2-5, 2026, in Chicago. Information regarding DDW can be found here. Patient Factors Associated wi

    4/23/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEI
    $AHI
    $ARDX
    $ASTS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEI
    $AHI
    $ARDX
    $ASTS
    Leadership Updates

    Live Leadership Updates

    View All

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

    WALTHAM, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Rajani Dinavahi, MD, as Chief Medical Officer (CMO). Dr. Dinavahi brings more than two decades of experience in healthcare and biotechnology, spanning multiple therapeutic areas and modalities. She has extensive experience across immuno-oncology, autoimmune diseases, metabolic disease, nephrology and transplantation, with a track record of advancing programs from early development through Phase 3 and regulatory approval. Dr. Dinavahi m

    4/1/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Former Fenbushi Capital Executive Peter Yang Joins Chaince Digital as Head of Digital Assets to Spearhead Tokenization Expansion

    New York, NY, March 26, 2026 (GLOBE NEWSWIRE) -- Chaince Digital Holdings Inc. ("Chaince Digital" or the "Company") (NASDAQ:CD) (formerly Mercurity Fintech Holding Inc.), a digital asset infrastructure and financial services platform bridging traditional capital markets with blockchain technology, today announced the appointment of Peter Yang as Head of Digital Assets. In this newly created role, Mr. Yang will oversee the Company's digital asset strategy, with a primary focus on expanding its tokenization platform and institutional partnerships. He will lead corporate development initiatives, strategic investments and acquisitions, and ecosystem growth across the Company's digital asset a

    3/26/26 9:00:00 AM ET
    $CD
    Finance: Consumer Services
    Finance

    $AEI
    $AHI
    $ARDX
    $ASTS
    Financials

    Live finance-specific insights

    View All

    Ebang International Reports Financial Results for Fiscal Year 2025

    IRVING, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (NASDAQ:EBON, the "Company, " "we" or "our")), today announced its financial results for the fiscal year ended December 31, 2025. Operational and Financial Highlights for Fiscal Year 2025 Total net revenues in the 2025 fiscal year increased by 11.4% to US$6.5 million, from US$5.9 million in the 2024 fiscal year. Gross profit in the 2025 fiscal year was US$0.4 million, compared to a gross profit of US$1.2 million in the 2024 fiscal year. Net loss in the 2025 fiscal year was US$14.2 million, compared to US$20.9 million in the 2024 fiscal year. Mr. Dong Hu, Chairman and Chief Executive Officer of the Comp

    4/24/26 4:15:00 PM ET
    $EBON
    Semiconductors
    Technology

    Hut 8 Schedules First Quarter 2026 Earnings Release and Conference Call

    MIAMI, April 17, 2026 /PRNewswire/ -- Hut 8 Corp. ((Nasdaq, TSX:HUT) ("Hut 8" or the "Company"), an energy infrastructure platform integrating power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases, today announced it will release financial results for the first quarter of 2026 before the market opens on May 6, 2026. The Company will host a conference call and webcast to review the results on the same day at 8:30 a.m. ET. Conference Call and Webcast DetailsDate: Wednesday, May 6, 2026Time: 8:30 a.m. ETTo register for the webcast,

    4/17/26 6:30:00 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    Riot Announces First Quarter 2026 Earnings Conference Call

    CASTLE ROCK, Colo., April 16, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announced today that it has scheduled its first quarter 2026 earnings conference call for Thursday, April 30, 2026, at 4:30 P.M. EST. This conference call will be available through an audio-only webcast. Please use this link here to register. Participants who choose to dial into the call in the United States or internationally, please use this link here to register. A replay of the webcast will be available after the call ends, through this link. About Riot Plat

    4/16/26 4:30:00 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    $AEI
    $AHI
    $ARDX
    $ASTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AST SpaceMobile Inc.

    SC 13D/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    11/20/24 9:59:14 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by MARA Holdings Inc.

    SC 13G/A - MARA Holdings, Inc. (0001507605) (Subject)

    11/14/24 6:13:30 PM ET
    $MARA
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Ardelyx Inc.

    SC 13G/A - ARDELYX, INC. (0001437402) (Subject)

    11/14/24 4:08:33 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care